Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

5.01USD
4:00pm EDT
Price Change (% chg)

$0.02 (+0.40%)
Prev Close
$4.99
Open
$5.01
Day's High
$5.05
Day's Low
$4.88
Volume
6,370
Avg. Vol
27,052
52-wk High
$7.73
52-wk Low
$3.82

NYMX.OQ

Chart for NYMX.OQ

About

Nymox Pharmaceutical Corporation (Nymox) is a biopharmaceutical company. The Company focuses on developing NX-1207, a treatment for benign prostatic hyperplasia (BPH) which is in Phase III trials in the United States. The Company has research and development (R&D) pipeline of products in development for the treatment of such... (more)

Overall

Beta: 0.70
Market Cap (Mil.): $176.65
Shares Outstanding (Mil.): 35.40
Dividend: --
Yield (%): --

Financials

  NYMX.OQ Industry Sector
P/E (TTM): -- 154.10 33.86
EPS (TTM): -0.17 -- --
ROI: -- -1.61 17.53
ROE: -- -6.70 18.34
Search Stocks

Incorrect biopsy results cloud Nymox Pharma prostate cancer study

- Nymox Pharmaceutical Corp said its experimental prostate cancer drug reduced the progression of cancer in patients, but it could not determine if the study succeeded in meeting pre-determined goals due to a high rate of incorrect biopsies.

30 Apr 2014

Incorrect biopsy results cloud Nymox Pharma prostate cancer study

April 30 - Nymox Pharmaceutical Corp said its experimental prostate cancer drug reduced the progression of cancer in patients, but it could not determine if the study succeeded in meeting pre-determined goals due to a high rate of incorrect biopsies.

30 Apr 2014

Competitors

  Price Change
Siemens AG (SIEGn.DE) €90.66 -0.97
Johnson & Johnson (JNJ.N) $103.13 +0.50
Pfizer Inc. (PFE.N) $29.11 +0.51
Novartis AG (NOVN.VX) CHF85.75 +0.35
Merck & Co., Inc. (MRK.N) $57.61 +0.98
Roche Holding Ltd. (ROG.VX) CHF278.00 -1.40
Abbott Laboratories (ABT.N) $42.46 +0.03
AstraZeneca plc (AZN.L) 4,327.50p -7.00
Eli Lilly and Co (LLY.N) $66.05 +1.70
Bristol-Myers Squibb Co (BMY.N) $53.63 +1.13

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Factual Report
$138.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks